Nonprofit · EIN 51-0181215
ISRAEL CANCER RESEARCH FUND INC
Tax-exempt · NEW YORK, NY 10017
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | 990 | $9,064,574 | $6,298,074 | $2,766,500 | $20,966,521 | $2,420,122 | $18,546,399 |
| December 31, 2023 | 990 | $7,728,171 | $6,353,295 | $1,374,876 | $19,252,119 | $3,284,864 | $15,967,255 |
Financial details: 990 for the year ended December 31, 2024
Revenue
- Contributions, gifts and grants
- $7,669,629
- Program service revenue
- $0
- Investment income
- $1,553,355
- Net gain from sales of assets
- $1,050,634
- Net income from fundraising events
- -$158,410
- Other revenue
- -$158,410
Expenses
- Grants and similar amounts paid
- $3,657,154
- Compensation of officers, directors and key employees
- $830,422
- Other salaries and wages
- $812,024
- Salaries, compensation and benefits (total)
- $1,864,230
- Professional fundraising fees
- $0
- Legal fees
- $23,392
- Accounting fees
- $66,890
- Occupancy
- $82,951
- Travel
- $33,727
- Depreciation
- $62,170
- Program services (functional)
- $4,397,049
- Management and general (functional)
- $676,706
- Fundraising (functional)
- $1,224,319
Balance sheet and other
- Total assets, start of year
- $19,252,119
- Total assets, end of year
- $20,966,521
- Total liabilities, end of year
- $2,420,122
- Net assets, end of year
- $18,546,399
- Land, buildings and equipment
- $123,808
- Publicly traded securities
- $15,542,928
- Net assets without donor restrictions
- $11,827,409
- Net assets with donor restrictions
- $6,718,990
- Gross receipts
- $19,918,132
- Employees
- 13
- Volunteers
- 45
- Year formed
- 1975
- State of legal domicile
- NY
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2024, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| ALAN HERMAN | EXECUTIVE DIRECTOR Officer | 40 | $246,274 | $79,703 |
| ALLYSON GREENFIELD | CHICAGO EXECUTIVE DIRECTOR Key employee | 40 | $155,587 | $38,383 |
| TANIA ORENSTEIN | CONTROLLER Key employee | 40 | $176,015 | $13,410 |
| DAVID KWESKIN | CONNECTICUT DIRECTOR Highest-paid employee | 40 | $117,987 | $8,677 |
| BERYL CHERNOV | FORMER NATIONAL EXECUTIVE DIR.(1/24) Officer | 40 | $98,640 | $22,409 |
| DAVID ABRAMSON | PRESIDENT Trustee or director, Officer | 2 | $0 | $0 |
| BRYNA GOLDBERG | CHAIR Trustee or director, Officer | 2 | $0 | $0 |
| ARNOLD M BASKIES MD | VICE PRESIDENT Trustee or director, Officer | 2 | $0 | $0 |
| NANCY MAIZELS PHD | VICE PRESIDENT Trustee or director, Officer | 2 | $0 | $0 |
| RICHARD EDELHEIT | TREASURER Trustee or director, Officer | 2 | $0 | $0 |
| CYNTHIA PERL | SECRETARY Trustee or director, Officer | 2 | $0 | $0 |
| BONNIE E FISH | EXECUTIVE COMMITTEE MEMBER Trustee or director | 2 | $0 | $0 |
| LESLIE R FREEDMAN PHD | EXECUTIVE COMMITTEE MEMBER Trustee or director | 2 | $0 | $0 |
| LISA OVED | EXECUTIVE COMMITTEE MEMBER Trustee or director | 2 | $0 | $0 |
| CHARLES SERLIN | EXECUTIVE COMMITTEE MEMBER Trustee or director | 2 | $0 | $0 |
28 more people on this return
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| ROBERT BARD | TRUSTEE Trustee or director | 2 | $0 |
| BRUCE BARRON | TRUSTEE Trustee or director | 2 | $0 |
| CHARLES BEN DAYAN | TRUSTEE Trustee or director | 2 | $0 |
| JEFFREY BERNSTEIN | TRUSTEE Trustee or director | 2 | $0 |
| JEFFREY BLY | TRUSTEE Trustee or director | 2 | $0 |
| VERA FINKELSTEIN | TRUSTEE Trustee or director | 2 | $0 |
| PAUL T FOX | TRUSTEE Trustee or director | 2 | $0 |
| TAMIR GILAT | TRUSTEE Trustee or director | 2 | $0 |
| BRAD GOLDHAR | TRUSTEE Trustee or director | 2 | $0 |
| KENNETH E GOODMAN | TRUSTEE Trustee or director | 2 | $0 |
| ROBERT GREENE | TRUSTEE Trustee or director | 2 | $0 |
| MARYANNE GREENFIELD | TRUSTEE Trustee or director | 2 | $0 |
| SAMUEL HERZFELD | TRUSTEE Trustee or director | 2 | $0 |
| ALISON HIMEL | TRUSTEE Trustee or director | 2 | $0 |
| MARK A ISRAEL MD | TRUSTEE Trustee or director | 2 | $0 |
| BARBARA KASELL | TRUSTEE Trustee or director | 2 | $0 |
| SUSAN MATTESON KING | TRUSTEE Trustee or director | 2 | $0 |
| RICHARD LIPKIN | TRUSTEE Trustee or director | 2 | $0 |
| DAVID MALKIN MD | TRUSTEE Trustee or director | 2 | $0 |
| LEN MARK | TRUSTEE Trustee or director | 2 | $0 |
| PATRICK MUNDT | TRUSTEE Trustee or director | 2 | $0 |
| LISA OVED | TRUSTEE Trustee or director | 2 | $0 |
| JOEL PELOFSKY | TRUSTEE Trustee or director | 2 | $0 |
| JERRY SILBER | TRUSTEE Trustee or director | 2 | $0 |
| GERELD SOFF MD | TRUSTEE Trustee or director | 2 | $0 |
| MATTHEW WEITZMAN PHD | TRUSTEE Trustee or director | 2 | $0 |
| JULIA WEKSLER | TRUSTEE Trustee or director | 2 | $0 |
| SIDNEY J WINAWER MD | TRUSTEE Trustee or director | 2 | $0 |
990 for the year ended December 31, 2023: 47 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| BERYL CHERNOV | NATIONAL EXECUTIVE DIRECTOR Officer | 40 | $325,941 | $69,497 |
| ALAN HERMAN | EXECUTIVE DIRECTOR, NEW YORK Key employee | 40 | $215,128 | $74,760 |
| ALLYSON MARKS-GREENFIELD | EXECUTIVE DIRECTOR, CHICAGO Key employee | 40 | $152,770 | $35,627 |
| TANIA ORENSTEIN | CONTROLLER Key employee | 40 | $165,890 | $12,610 |
| DAVID KWESKIN | CONNECTICUT DIRECTOR Highest-paid employee | 40 | $114,762 | $7,917 |
| DAVID ABRAMSON | PRESIDENT Trustee or director, Officer | 2 | $0 | $0 |
| BRYNA GOLDBERG | CHAIR Trustee or director, Officer | 2 | $0 | $0 |
| ARNOLD M BASKIES MD | VICE PRESIDENT Trustee or director, Officer | 2 | $0 | $0 |
| NANCY MAIZELS PHD | VICE PRESIDENT Trustee or director, Officer | 2 | $0 | $0 |
| RICHARD EDELHEIT | TREASURER Trustee or director, Officer | 2 | $0 | $0 |
| CYNTHIA PERL | SECRETARY Trustee or director, Officer | 2 | $0 | $0 |
| JORDANNA FEIFER | EXECUTIVE COMMITTEE MEMBER Trustee or director | 2 | $0 | $0 |
| BONNIE E FISH | EXECUTIVE COMMITTEE MEMBER Trustee or director | 2 | $0 | $0 |
| LESLIE FREEDMAN | EXECUTIVE COMMITTEE MEMBER Trustee or director | 2 | $0 | $0 |
| LISA OVED | EXECUTIVE COMMITTEE MEMBER Trustee or director | 2 | $0 | $0 |
| CHARLES SERLIN | EXECUTIVE COMMITTEE MEMBER Trustee or director | 2 | $0 | $0 |
| ROBERT BARD | TRUSTEE Trustee or director | 2 | $0 | $0 |
| BRUCE BARRON | TRUSTEE Trustee or director | 2 | $0 | $0 |
| ALAN BERK | TRUSTEE Trustee or director | 2 | $0 | $0 |
| CHARLES BEN DAYAN | TRUSTEE Trustee or director | 2 | $0 | $0 |
| JEFFREY BERNSTEIN | TRUSTEE Trustee or director | 2 | $0 | $0 |
| JEFFREY BLY | TRUSTEE Trustee or director | 2 | $0 | $0 |
| MICHELLE CHREIN | TRUSTEE Trustee or director | 2 | $0 | $0 |
| MARSHA DEAKTER | TRUSTEE Trustee or director | 2 | $0 | $0 |
| ROB DENSEN | TRUSTEE Trustee or director | 2 | $0 | $0 |
| VERA FINKELSTEIN | TRUSTEE Trustee or director | 2 | $0 | $0 |
| PAUL T FOX | TRUSTEE Trustee or director | 2 | $0 | $0 |
| TAMIR GILAT | TRUSTEE Trustee or director | 2 | $0 | $0 |
| BRAD GOLDHAR | TRUSTEE Trustee or director | 2 | $0 | $0 |
| KENNETH E GOODMAN | TRUSTEE Trustee or director | 2 | $0 | $0 |
| GARY I GRAD MD | TRUSTEE Trustee or director | 2 | $0 | $0 |
| ROBERT GREENE | TRUSTEE Trustee or director | 2 | $0 | $0 |
| MARYANNE GREENFIELD | TRUSTEE Trustee or director | 2 | $0 | $0 |
| SAMUEL HERZFELD | TRUSTEE Trustee or director | 2 | $0 | $0 |
| MARK A ISRAEL MD | TRUSTEE Trustee or director | 2 | $0 | $0 |
| BARBARA KASELL | TRUSTEE Trustee or director | 2 | $0 | $0 |
| SUSAN MATTESON KING | TRUSTEE Trustee or director | 2 | $0 | $0 |
| RICHARD LIPKIN | TRUSTEE Trustee or director | 2 | $0 | $0 |
| MICHELLE MAKORI | TRUSTEE Trustee or director | 2 | $0 | $0 |
| DAVID MALKIN MD | TRUSTEE Trustee or director | 2 | $0 | $0 |
| LEN MARK | TRUSTEE Trustee or director | 2 | $0 | $0 |
| PATRICK MUNDT | TRUSTEE Trustee or director | 2 | $0 | $0 |
| JOEL PELOFSKY | TRUSTEE Trustee or director | 2 | $0 | $0 |
| TOM PELED | TRUSTEE Trustee or director | 2 | $0 | $0 |
| GERELD SOFF MD | TRUSTEE Trustee or director | 2 | $0 | $0 |
| JULIA WEKSLER | TRUSTEE Trustee or director | 2 | $0 | $0 |
| SIDNEY J WINAWER MD | TRUSTEE Trustee or director | 2 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 52 VANDERBILT AVE RM 1410, NEW YORK, NY 10017-3835
- Principal officer (990 for 2024)
- RICHARD EDELHEIT, 52 VANDERBILT AVENUE 1410, NEW YORK, NY 10017
- Signed the 990
- RICHARD EDELHEIT, TREASURER
- Phone
- (212) 969-9800
- Website
- WWW.ICRFONLINE.ORG
- Return prepared by
- CITRIN COOPERMAN ADVISORS LLC
Mission
TO SUPPORT CANCER RESEARCH IN ISRAEL, FOR THE BENEFIT OF ISRAEL AND ALL MANKIND.
Program accomplishments
- PROVIDED CANCER RESEARCH FUNDING FOR ISRAELI SCIENTISTS. ICRF IS THE LARGEST NON-PROFIT IN NORTH AMERICA DEDICATED TO SUPPORTING CANCER RESEARCH IN ISRAEL. OVER THE LAST NEARLY 50 YEARS, ICRF HAS PROVIDED MORE THAN $98 MILLION TO SUPPORT CANCER RESEARCH IN ISRAEL, FUNDING NEARLY 3,000 RESEARCH PROJECTS. IN 2024, WE AWARDED 58 RESEARCH GRANTS VALUED AT NEARLY $3.6M. TYPICALLY, 60-80 GRANTS ARE FUNDED ANNUALLY, BASED ON AN EVALUATION AND PRIORITIZATION BY INDEPENDENT REVIEW PANELS CONSISTING OF 40-50 LEADING CANCER SCIENTISTS FROM NORTH AMERICAN BIOMEDICAL RESEARCH CENTERS. ICRF GRANT CATEGORIES ARE TAILORED TO SUPPORT CANCER RESEARCHERS AT ALL OF THE VARIOUS STAGES OF THEIR CAREERS, AND WE ARE PROUD TO HAVE HELPED SUPPORT MANY OF TODAY'S MOST OUTSTANDING SCIENTISTS AT THE EARLIEST STAGES IN THEIR CAREERS. ICRF SEEKS TO CAPITALIZE ON THE SIGNIFICANTLY LOWER COSTS OF CONDUCTING CANCER RESEARCH IN ISRAEL. ALL AWARDS GO DIRECTLY TO THE DESIGNATED RESEARCHER WITHOUT ANY REDUCTION FOR OVERHEAD.Expenses $3,027,012 · grants $2,527,154
- SUPPORTED THE DEVELOPMENT OF THE NEXT GENERATION OF ISRAELI CANCER SCIENTISTS. ICRF IS COMMITTED TO FACILITATING THE DEVELOPMENT OF FUTURE CANCER SCIENTISTS IN ISRAEL. TOWARDS THIS END ICRF FUNDS THREE TYPES OF GRANTS: POSTDOCTORAL FELLOWSHIP AWARDS, RESEARCH CAREER DEVELOPMENT AWARDS, AND CLINICAL RESEARCH CAREER DEVELOPMENT AWARDS. FELLOWSHIPS SUPPORT MDS AND PHDS WHO HAVE JUST COMPLETED THEIR POSTGRADUATE TRAINING. THESE AWARDS CAN BE USED TO SUPPORT SALARIES OR RESEARCH COSTS, WHILE THESE INDIVIDUALS APPRENTICE IN THE LABORATORIES OF SENIOR INVESTIGATORS. CAREER DEVELOPMENT AWARDS ARE TO ENHANCE THE RESEARCH CAPABILITIES OF YOUNG ISRAELI SCIENTISTS IN THE FORMATIVE PHASE OF THEIR CAREERS. CANDIDATES MUST HAVE DEMONSTRATED OUTSTANDING POTENTIAL FOR CONTRIBUTIONS TO CANCER RESEARCH AND MUST EXHIBIT GREAT POTENTIAL TO BECOME INDEPENDENT INVESTIGATORS RESEARCH. SUPPORTING THESE NEWLY LAUNCHED SCIENTISTS, ENHANCES THEIR OPPORTUNITIES IN ISRAEL AND ALLOWS THEM TO OPTIMIZE THEIR WORK WITHOUT EMIGRATING TO OTHER ADVANCED COUNTRIES.Expenses $879,006 · grants $725,000
- SUPPORTED COLLABORATIVE CANCER RESEARCH CONDUCTED BY ISRAELI SCIENTISTS IN ASSOCIATION WITH NORTH AMERICAN CANCER SCIENTISTS. CANCER SCIENCE OFTENTIMES REQUIRES MULTI-DISCIPLINARY APPROACHES, ENGAGEMENT WITH HIGHLY SPECIALIZED AREAS OF SCIENCE, AND EXPENSIVE EQUIPMENT THAT IS NOT EASILY ACCESSED. COLLABORATIONS BETWEEN SCIENTISTS IN ISRAEL AND NORTH AMERICA CAN ADDRESS THESE CHALLENGES, FOSTER UNEXPECTED SYNERGIES, AND ENHANCE BOTH INTELLECTUAL CURIOSITY AND INNOVATION. ICRF PROMOTES COLLABORATION BY SUPPORTING GRANTS THAT FUND PROMISING CANCER RESEARCH PROJECTS BEING CONDUCTED ON A COLLABORATIVE BASIS BETWEEN INVESTIGATORS IN ISRAEL AND AN AMERICAN OR CANADIAN RESEARCH INSTITUTION.Expenses $491,031 · grants $405,000
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | Not on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 51-0181215
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 1976
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Assets (IRS master file)
- $20,966,521
- Income (IRS master file)
- $19,918,132
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2024 | $9,064,574 | $6,298,074 | $20,966,521 | XML |
| 990 | December 2023 | $7,728,171 | $6,353,295 | $19,252,119 | XML |
| 990 | December 2022 | $5,734,601 | $6,217,607 | $16,331,164 | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990 | December 2018 | – | – | – | IRS |
| 990 | December 2017 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 51-0181215).
Questions about ISRAEL CANCER RESEARCH FUND INC
- What is the EIN of ISRAEL CANCER RESEARCH FUND INC?
- The employer identification number (EIN) of ISRAEL CANCER RESEARCH FUND INC is 51-0181215.
- Is ISRAEL CANCER RESEARCH FUND INC tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1976.
- Are donations to ISRAEL CANCER RESEARCH FUND INC tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does ISRAEL CANCER RESEARCH FUND INC file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of ISRAEL CANCER RESEARCH FUND INC due?
- The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did ISRAEL CANCER RESEARCH FUND INC last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2024.
- Who is the principal officer of ISRAEL CANCER RESEARCH FUND INC?
- The 990 for the year ended December 31, 2024 names RICHARD EDELHEIT.
- Who are the officers and directors of ISRAEL CANCER RESEARCH FUND INC?
- The 990 for the year ended December 31, 2024 lists 43 people; 5 received compensation from the organization, the highest $246,274 (ALAN HERMAN, EXECUTIVE DIRECTOR).
- How much revenue does ISRAEL CANCER RESEARCH FUND INC have?
- On its 990 for the year ended December 31, 2024 it reported revenue of $9,064,574, expenses of $6,298,074 and total assets of $20,966,521 at year end.
Other nonprofits in NEW YORK
- NEW YORK UNIVERSITY EIN 13-5562308 · last filed 990 for 2025
- HEALTHFIRST PHSP INC EIN 13-3783732 · last filed 990 for 2024
- THE NEW YORK AND PRESBYTERIAN HOSPITAL EIN 13-3957095 · last filed 990 for 2024
- NYU LANGONE HOSPITALS EIN 13-3971298 · last filed 990 for 2025
- MEMORIAL SLOAN-KETTERING CANCER CENTER EIN 91-2154267 · last filed 990 for 2024
- TRUSTEES OF COLUMBIA UNIVERSITY EIN 13-5598093 · last filed 990 for 2025
- HEALTHFIRST HEALTH PLAN INC EIN 11-3029569 · last filed 990 for 2024
- GS DONOR ADVISED PHILANTHROPY FUND FOR WEALTH MANAGEMENT INC EIN 31-1774905 · last filed 990 for 2024